Streetbeat News

Analyst Ratings

OI

Four analysts have provided ratings for O-I Glass (NYSE:OI) in the last quarter, with an average price target of $28.0, implying an upside from the current price of $17.025. The current average has decreased by 2.34% from the previous average price target of $28.67.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 7:00 pm

PLRX

Pliant Therapeutics Inc (NASDAQ:PLRX) announced positive data from the INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis (PSC) and suspected moderate to severe liver fibrosis. The trial met its primary and secondary endpoints, demonstrating that bexotegrast was well tolerated and its plasma concentrations increased with dose. The trial's exploratory efficacy endpoints showed bexotegrast reduced both ELF scores and PRO-C3 levels at Week 12 at all doses relative to placebo. PLRX shares were up 13.10% at $16.48 on the last check Tuesday.

Portfolio Pulse from Vandana Singh

September 26, 2023 | 6:56 pm

HD

A significant investor has taken a bearish stance on Home Depot (NYSE:HD), with 63% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $290.0 to $375.0 for Home Depot over the last 3 months. Evercore ISI Group maintains an Outperform rating on Home Depot with a price target of $370, while Stifel and HSBC have downgraded their actions to Hold with price targets of $350 and $365 respectively.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 6:46 pm

CYBN

DMTTF

UK-based Small Pharma (OTCQB:DMTTF) has released findings from its Phase 1b study on the interaction of its DMT compound, SPL026, and selective serotonin reuptake inhibitors (SSRIs) for the treatment of major depressive disorder (MDD). The study found that SPL026 was well-tolerated by all 17 patients, with no serious adverse events reported. The treatment showed greater antidepressant effects in the SSRI cohort, suggesting enhanced efficacy when administered jointly with SSRIs. Small Pharma's CEO mentioned exploring these findings as part of the integrated DMT program with Cybin (NYSE:CYBN).

Portfolio Pulse from Lara Goldstein

September 26, 2023 | 6:31 pm

V

A significant bearish stance has been taken on Visa (NYSE:V) as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 27% bullish and 72% bearish. The whales have been targeting a price range from $130.0 to $260.0 for Visa over the last 3 months. Visa's stock price is currently down by 1.44% at $229.99. Wedbush, Mizuho, and Baird have downgraded their actions on Visa with price targets of $270, $255, and $284 respectively.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 6:31 pm

BA

A large investor has taken a bearish stance on Boeing (NYSE:BA), as indicated by a significant position in options. The sentiment among these big-money traders is split, with 31% bullish and 68% bearish. The whales have been targeting a price range from $150.0 to $280.0 for Boeing over the last 3 months. Currently, the price of BA is down -1.43% at $195.94. Citigroup, Susquehanna, and TD Cowen have maintained their ratings on Boeing with price targets of $285, $270, and $260 respectively.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 6:31 pm

LUV

Southwest Airlines' shares are trading lower after Bernstein maintained a Market Perform rating on the stock but lowered its price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 6:23 pm

SNAP

HSBC has initiated coverage on Snap with a Reduce rating and a price target of $7.50. This has led to a decrease in Snap's share price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 6:16 pm

CDW

CDW's short percent of float has fallen 5.19% since its last report, with 1.51 million shares sold short, which is 1.28% of all regular shares available for trading. It would take traders 3.49 days to cover their short positions on average. CDW's peer group average for short interest as a percentage of float is 3.22%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 6:15 pm

BKR

Baker Hughes's (NYSE:BKR) short percent of float has risen 4.93% since its last report, with 15.66 million shares sold short, which is 2.34% of all regular shares available for trading. It would take traders 3.04 days to cover their short positions on average. Compared to its peers, Baker Hughes has less short interest as a percentage of float, with the average being 5.35%.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 6:15 pm